INTERVENTIONS |
Intervention type
|
Intervention name
|
Dose
|
Duration
|
Intervention description
|
Group size
|
Nature of control
|
Control Group |
suprascapular nerve block |
receive suprascapular nerve block with 15ml of o.5%bupivacaine only pre operatively then will receive general anesthesia. |
single shot |
receive suprascapular nerve block with 15ml of o.5%bupivacaine only pre operatively then will receive general anesthesia.after surgery the patient assessed for 24hour for pain |
20 |
Active-Treatment of Control Group |
Experimental Group |
suprascapular nerve block |
patients will receive ultrasound guided suprascapular nerve block with 15ml 0.5% bupivacine and 0.8mg nalbuphine pre operatively then the patientd will be receive general anesthesia. |
single shot |
patients will receive ultrasound guided suprascapular nerve block with 15ml 0.5% bupivacine and 0.8mg nalbuphine pre operatively then the patientd will be receive general anesthesia.after surgery patients assessed for pain severity |
20 |
|
Experimental Group |
suprascapular nerve block |
patients will receive ultrasound guided suprascapular nerve block with 15ml 0.5% bupivacaine and 1.8mg nalbuphine pre operatively then will receive general anesthesia. |
single shot |
patients will receive ultrasound guided suprascapular nerve block with 15ml 0.5% bupivacaine and 1.8mg nalbuphine pre operatively then will receive general anesthesia.after surgery patients assessed for pain severity |
20 |
|
Experimental Group |
suprascapular nerve block |
patients will receive ultrasound guided suprascapular nerve block with 15ml 0.5% bupivacaine and 2.4mg nalbuphine pre operatively then will be given general anesthesia |
single shot |
patients will receive ultrasound guided suprascapular nerve block with 15ml 0.5% bupivacaine and 2.4mg nalbuphine pre operatively then will be given general anesthesia after surgery patients assessed for pain severity |
20 |
|